miRNA-15a/16: as tumor suppressors and more (Q38564093)

4 September 2017

1 reference

title

miRNA-15a/16: as tumor suppressors and more (English)

1 reference

4 September 2017

Enyu Huang

1

1 reference

4 September 2017

Ronghua Liu

series ordinal

2

1 reference

4 September 2017

Yiwei Chu

series ordinal

3

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

11

1 reference

4 September 2017

16

1 reference

4 September 2017

2351-2363

1 reference

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

4 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Prognostic significance of microRNA-16 expression in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Identifying microRNA/mRNA dysregulations in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Differential expression of miRNAs in the serum of patients with high-risk oral lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

U6 is not a suitable endogenous control for the quantification of circulating microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Analysis of circulating microRNAs in adrenocortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

miR-34 - a microRNA replacement therapy is headed to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

Mir-34: a new weapon against cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.101

21 January 2018

Identifiers

DOI

10.2217/FON.15.101

1 reference

4 September 2017

1 reference